| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |